PRESS RELEASE: Sign Up for a Complimentary Inside Health Policy Trial
Contact: Steve Reilly
WASHINGTON, DC USA -- HEALTHCARE UPDATE NEWS SERVICE -- FEBRUARY 19, 2020: Sign up for a one-month free trial to Inside Health Policy, the online news service on health care policy from the regulatory reporting experts at Inside Washington Publishers. Your trial will automatically expire at the end of 30 days.
HERE IS A SAMPLE OF THE LATEST INSIDE HEALTH POLICY STORIES THAT YOU CAN READ WITH YOUR FREE TRIAL:
Verma: Medicaid Supplemental Pay Reg Opponents Are Alarmists
CMS Administrator Seema Verma said those alleging the agency's proposed Medicaid Fiscal Accountability Regulation will cut billions of dollars from Medicaid are alarmists without credibility, and she tried to assure stakeholders in a blog post Wednesday that the rule is not intended to scale back Medicaid pay. Verma added that CMS will work with states to transition problematic pay arrangements to ones its deems more permissible.
Gottlieb Warns Senate Of Supply Chain Issues Exposed By Coronavirus
If the coronavirus epidemic continues to spread in China, the United States will begin to see shortages of drugs and medical supplies, former FDA chief Scott Gottlieb warned lawmakers during a Senate Homeland Security and Governmental Affairs Committee roundtable meeting Wednesday (Feb. 12).
D.C. Circuit Invalidates Arkansas' Medicaid Work Requirements
A federal appeals court on Friday (Feb. 14) ruled that work requirements do not advance the purpose of Medicaid, dealing another serious blow to one of the Trump administration's signature health care policies.
While Friday's ruling technically applies only to Arkansas' attempt to add work requirements to Medicaid, it is sure to set a powerful precedent for other states seeking to use 1115 waivers to adopt the controversial policy. A few of those states have already been hit with lawsuits similar to the Arkansas litigation.
Azar Says Budget Backs Senate Bill; White House Disagrees
Countering HHS Secretary Alex Azar's statements Thursday (Feb. 13), a senior administration official insisted that the 2021 White House budget request does not endorse the Senate Finance Committee's drug pricing bill.
"Endorsing a particular bill can tie your hands. What matters is what's in the budget," a senior administration official said when asked about Azar's comments in the Senate.
You can try Inside Health Policy for the next month with absolutely no obligation. Your trial includes online access to the newsletter you choose: Inside CMS, FDA Week, Health Exchange Alert, or Inside Drug Pricing -- and please call us if you want access to a second newsletter with your trial. Plus, if you choose to subscribe, we'll offer you 50% off for the first year of access.
For more information about the 50% off, first-year savings, contact Steve Reilly at 703-562-8992, or e-mail him at firstname.lastname@example.org.